Spero Therapeutics: A Biotech Investment Opportunity That You Shouldn't Miss. In the ever-evolving world of biotechnology, one company that has recently caught the attention of investors and industry analysts alike is Spero Therapeutics (NASDAQ: $SPRO). HC Wainwright & Co., a reputable full-service investment bank, has reiterated its 'Buy' rating on the company's stock and maintained a price target of $7. This not only indicates the...
Spero Therapeutics' P/S lags behind the industry despite a strong price move. Its forecast for shrinking revenue and poor outlook justify the low P/S ratio. These conditions form a barrier for the share price at these levels.
セペロ・セラピューティクスに関するコメント
In the ever-evolving world of biotechnology, one company that has recently caught the attention of investors and industry analysts alike is Spero Therapeutics (NASDAQ: $SPRO). HC Wainwright & Co., a reputable full-service investment bank, has reiterated its 'Buy' rating on the company's stock and maintained a price target of $7. This not only indicates the...
まだコメントはありません